Mongolia vs Peru: Contraceptive prevalence, any modern method
Contraceptive prevalence, any modern method over time
- Mongolia
- Peru
How they compare
Peru currently reports 41.7% against 36.6% in Mongolia, a difference of 5.1%.
That makes Peru's figure about 1.1 times Mongolia's.
The two have swapped places 2 times across 6 shared years of data; in 1996 it was Peru ahead.
Mongolia ranks 26th and Peru ranks 23rd of 62 countries.
Across the 3 decades both report, Mongolia averaged higher in 2 and Peru in 1.
Head to head by decade
| Decade | Mongolia | Peru | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 26.0% | 26.4% | 0.4% | Peru |
| 2000s | 40.2% | 32.5% | 7.7% | Mongolia |
| 2010s | 37.1% | 36.5% | 0.6% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher contraceptive prevalence, any modern method, Mongolia or Peru?
- Peru, at 41.7% against 36.6% in Mongolia as of 2022.
- What is the difference in contraceptive prevalence, any modern method between Mongolia and Peru?
- 5.1%, with Peru ahead.
- How many years of comparable data are there for Mongolia and Peru?
- 6 years are reported by both, from 1996 to 2018.
- How do Mongolia and Peru rank globally for contraceptive prevalence, any modern method?
- Mongolia ranks 26th and Peru ranks 23rd of 62 countries.
- Where does this data come from?
- Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.